OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclin-Dependent Kinase 6 Is a Chromatin-Bound Cofactor for NF-κB-Dependent Gene Expression
Katja Handschick, Knut Beuerlein, Liane Jurida, et al.
Molecular Cell (2014) Vol. 53, Iss. 2, pp. 193-208
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Cyclin-dependent kinases
Marcos Malumbres
Genome biology (2014) Vol. 15, Iss. 6
Open Access | Times Cited: 1361

The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Mehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 685-712.e19
Open Access | Times Cited: 1007

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng, Eric S. Wang, Russell W. Jenkins, et al.
Cancer Discovery (2017) Vol. 8, Iss. 2, pp. 216-233
Open Access | Times Cited: 610

Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
Sivagami Giridharan, Mythily Srinivasan
Journal of Inflammation Research (2018) Vol. Volume 11, pp. 407-419
Open Access | Times Cited: 506

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation
Ruth Scheicher, Andrea Hoelbl‐Kovacic, Florian Bellutti, et al.
Blood (2014) Vol. 125, Iss. 1, pp. 90-101
Open Access | Times Cited: 215

Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6
Baishan Jiang, Eric S. Wang, Katherine A. Donovan, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 19, pp. 6321-6326
Open Access | Times Cited: 214

Cell-Cycle Proteins Control Production of Neutrophil Extracellular Traps
Borko Amulic, Sebastian Lorenz Knackstedt, Ulrike Abu Abed, et al.
Developmental Cell (2017) Vol. 43, Iss. 4, pp. 449-462.e5
Open Access | Times Cited: 204

TF-PROTACs Enable Targeted Degradation of Transcription Factors
Jing Liu, He Chen, H. Ümit Kanıskan, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 23, pp. 8902-8910
Open Access | Times Cited: 176

CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation
A-S Tigan, Florian Bellutti, Karoline Kollmann, et al.
Oncogene (2015) Vol. 35, Iss. 24, pp. 3083-3091
Open Access | Times Cited: 161

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia
Theresa Placke, Katrin Faber, Atsushi Nonami, et al.
Blood (2014) Vol. 124, Iss. 1, pp. 13-23
Open Access | Times Cited: 150

Targeting CDK6 in cancer: State of the art and new insights
Solomon Tadesse, Mingfeng Yu, Malika Kumarasiri, et al.
Cell Cycle (2015) Vol. 14, Iss. 20, pp. 3220-3230
Open Access | Times Cited: 129

miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
Bairong Xia, Shanshan Yang, Tianbo Liu, et al.
Molecular Cancer (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 129

Palbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor
Amy S. Clark, Thomas B. Karasic, Angela DeMichele, et al.
JAMA Oncology (2015) Vol. 2, Iss. 2, pp. 253-253
Closed Access | Times Cited: 115

Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6
Iris Z. Uras, Gina Walter, Ruth Scheicher, et al.
Blood (2016) Vol. 127, Iss. 23, pp. 2890-2902
Open Access | Times Cited: 111

HIF-1α restricts NF-κB dependent gene expression to control innate immunity signals
Daniel Bandarra, John Biddlestone, Sharon Mudie, et al.
Disease Models & Mechanisms (2014)
Open Access | Times Cited: 108

Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu, Zhibing Duan, Weijie Guo, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 96

The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells
Michael Poppe, Sascha Wittig, Liane Jurida, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 3, pp. e1006286-e1006286
Open Access | Times Cited: 94

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Daniel Arthur Corpuz Fisher, Jared S. Fowles, Amy Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 82

Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6356-6389
Closed Access | Times Cited: 46

Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma
Carmen Oi Ning Leung, Yang Yang, Rainbow Wing Hei Leung, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27

Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling
Hyunju Lee, Hyang‐Sook Hoe
Pharmacological Research (2023) Vol. 190, pp. 106725-106725
Open Access | Times Cited: 24

Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression
M. Lienhard Schmitz, Michael Kracht
Trends in Pharmacological Sciences (2015) Vol. 37, Iss. 2, pp. 101-113
Closed Access | Times Cited: 85

Advances in treatment of ulcerative colitis with herbs: From bench to bedside
Ping Wan
World Journal of Gastroenterology (2014) Vol. 20, Iss. 39, pp. 14099-14099
Open Access | Times Cited: 75

CDK6 Antagonizes p53-Induced Responses during Tumorigenesis
Florian Bellutti, Anca-Sarmiza Tigan, Sofie Nebenfuehr, et al.
Cancer Discovery (2018) Vol. 8, Iss. 7, pp. 884-897
Open Access | Times Cited: 70

Page 1 - Next Page

Scroll to top